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Zerumbone alleviates chronic constriction injury-induced allodynia and hyperalgesia 
through serotonin 5-HT receptors 
ABSTRACT 
Zerumbone, a bioactive sesquiterpene isolated from Zingiber zerumbet (Smith), has shown to 
exert antiallodynic and antihyperalgesic effects in neuropathic pain mice model in our recent 
study. The mechanism through which zerumbone alleviates neuropathic pain has yet to be 
elucidated. Thus, this study aimed to determine whether the serotonergic system, part of the 
descending pain modulation pathway, contributes to the antineuropathic effect of zerumbone. 
Participation of the serotonergic system in zerumbone-induced antiallodynia and 
antihyperalgesia was assessed using Dynamic Plantar Aesthesiometer von Frey test and 
Hargreaves plantar test respectively in chronic-constriction injury mice model. 
Administration of ρ-chlorophenylalanine (PCPA, 100 mg/kg, i.p.) for four consecutive days 
to deplete serotonin (5-HT) prior to zerumbone administration blocked the antiallodynic and 
antihyperalgesic effects of zerumbone. Further investigation with 5-HT receptor antagonists 
methiothepin (5-HT 1/6/7 receptor antagonist, 0.1 mg/kg), WAY-100635 (5-HT 1A receptor 
antagonist, 1 mg/kg), isamoltane (5-HT 1B receptor antagonist, 2.5 mg/kg), ketanserin (5-HT 
2A receptor antagonist, 0.3 mg/kg) and ondansetron (5-HT 3 receptor antagonist, 0.5 mg/kg) 
managed to significantly attenuate antiallodynic and antihyperalgesic effects of zerumbone 
(10 mg/kg). These findings demonstrate that zerumbone alleviates mechanical allodynia and 
thermal hyperalgesia through the descending serotonergic system via 5-HT receptors 1A, 1B, 
2A, 3, 6 and 7 in chronic constriction injury neuropathic pain mice. 
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